Living Well is the only self-care solution delivering psychological and behavioral support to cancer patients instantly, cost-effectively, and reliably.
Its clinically validated program, designed explicitly for cancer patients, reduces symptoms of stress, anxiety, and depression related to the diagnosis and treatment of cancer which improves patients' emotional functioning, quality of life, and overall outcomes.
Find out more about what Living Well can do for you throughout your cancer journey.
Find out more about how Living Well can support your patients and the care you provide.
Cancer not only affects the body, but also the mind, so for patients to receive truly adequate care, it is necessary to add a psychological dimension to the care they are receiving.
I strongly believe that Living Well is innovative and supportive, and that it provides excellent opportunities for patients to manage their feelings and emotions and, thus, improve the course of their overall treatment.
Living Well promotes scientifically validated behavioural change interventions that help cancer patients follow their treatment, enjoy a healthier lifestyle and improve their quality of life.
Despite major advances in overall cancer treatment, many patients continue to experience significant distress. We need to offer them help before their psychological concerns reach the crisis stage, as this may negatively affect their overall recovery and response to treatment.
We are a MedTech company that develops and brings digital solutions to market for oncology patients. Our products are ground-breaking in the field of psycho-oncology and offer comprehensive assistance during and after treatment. Psycho-oncological support is crucially important as it not only improves mental health, but also has a positive impact on the patients’ quality of life. By combining world-leading expertise in medicine and technology, our interdisciplinary team sets new standards in the industry.
We have developed a portfolio of digital health care medical products that covers the entirety of the behavioral treatment needs of cancer patients.
Our clinically validated, digital health care platform will soon be prescribed by doctors and therapists in Germany as a DiGA*, and will be reimbursed by the local healthcare system.
We aim to become the #1 digital health care provider for oncology globally, and we have have a clear pathway to get there.
Germany differentiates lifestyle applications from medical applications by calling them DiGA, which is an abbreviation for Digitale Gesundheitsanwendungen,
Daiichi Sankyo Germany seeks to support cancer care in a collaboration with Prosoma
for New Therapeutic Supporting Mental Health and Behavioural Needs of Cancer Patients
